Felypressin | CAS:56-59-7

We serve Felypressin CAS:56-59-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Felypressin

Chemical Name:Felypressin
CAS.NO:56-59-7
Synonyms:Felypressin
2-(Phenylalanine)-8-lysine vasopressin
Felypressin Acetate
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 1571.3±65.0 °C at 760 mmHg
Melting Point 254-257 °C
Molecular Formula C46H65N13O11S2
Molecular Weight 1040.219
Flash Point 904.1±34.3 °C
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.574
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Felypressin is a non-catecholamine vasoconstrictor that is chemically related to vasopressin, the posterior pituitary hormone. It is added to some local anaesthetics.



Contact us for information like Felypressin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Felypressin Acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Felypressin Use and application,Felypressin technical grade,usp/ep/jp grade.


Related News: Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.’s governing body.5-Amino-1H-imidazole-4-carboxamide hydrochloride manufacturer Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.’s governing body.2-Bromo-3-methylbutyric acid supplier It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.4-chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine vendor It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.But several border points remain open, and many medical workers fear that Hong Kong’s well-regarded health care system will be overwhelmed.